Mobile Testing Platform Performs World's Fastest Multiplex PCR and RT-PCR Analysis
|
By LabMedica International staff writers Posted on 29 Jun 2022 |

Polymerase Chain Reaction (PCR) is an enzymatic amplification technique that produces a large number of identical copies of a DNA or RNA fragment and visualizes it by fluorescence. This very fast, sensitive and sequence-specific technique is much more efficient than traditional culture-based diagnostic methods, which suffer from long delays in obtaining results (from several days to several weeks). This is currently the most relevant method for rapid detection of genetic sequences in a sample, for example those of bacteria or viruses causing infectious diseases. In addition to classical PCR, there are several other types of PCR such as RT-PCR (reverse transcription PCR), qPCR (quantitative PCR), dPCR (digital PCR) and ddPCR (droplet digital PCR). Now, a new techniques named hcPCR (high content PCR), combines the advantages of qPCR and dPCR, in order to detect a large number of targets per test (multiplexing) and obtain the maximum amount of information in record time.
The hcPCR technique has been developed at BforCure (Paris, France) with Chronos Dx, its mobile, easy-to-use PCR/RT-PCR testing tool that delivers in vitro diagnosis of many infectious diseases in less than 15 minutes. While real-time PCR or RT-PCR typically takes 35 minutes to one hour to detect genetic material, BforCure's Chronos Dx platform performs multiplex PCR and RT-PCR analysis in record time. With the company’s Bflash+ range of kits optimized for research purposes, it is even possible to obtain accurate test results in less than five minutes.
Chronos Dx is based on a combination of microfluidic and optical technologies, which allows for ultra-fast temperature changes in the reaction mixture, reduced PCR cycle times and the detection of multiple genetic targets present in a sample, all in a single test (multiplexing principle). Chronos Dx enables ultra-fast PCR tests to be performed on a wide range of infectious diseases (respiratory, digestive and sexually transmitted). The infectious disease PCR testing tool offers a reliable and rapid response to the needs of laboratories regarding the detection of microorganisms, whether in the medical, environmental or industrial fields. Mobile, easy to use and connected, the Chronos Dx platform can be directly used in delocalized "satellite laboratories", as close as possible to the needs of healthcare professionals. It allows medical laboratories to manage urgent samples by performing unit analyses of numerous contagious pathologies, in order to accelerate patient care.
Related Links:
BforCure
Latest Molecular Diagnostics News
- New Respiratory Panel Expands Pathogen Detection to 25 Targets
- Simple Nasal Swab May Reveal Early Signs of Alzheimer’s Disease
- Blood Biomarker Predicts Cognitive Outcomes After Cardiac Arrest
- Liquid Biopsy Enables Faster Diagnosis of Childhood Cancer in Africa
- Blood Test Helps Guide Treatment in Older Women with Breast Cancer
- Rapid Host-Response Test Distinguishes Bacterial and Viral Infections in Minutes
- Liquid Biopsy Method Pinpoints Disease Source From a Single Drop of Blood
- Study Reveals Widespread Errors in Gene Variant Naming
- New Blood Test Aims to Transform Liver Cancer Surveillance
- New Biomarkers Indicate Higher Liver Cancer Risk in Chronic Hepatitis B Patients
- Precision Analyzer Reveals ‘Chameleon Proteins’ Causing Intractable Diseases
- Alzheimer's Blood Marker Could Improve Detection of Heart and Kidney Diseases
- Single Blood Test Predicts Heart Diseases 15 Years Before Onset
- Blood Immune 'Fingerprint' Predicts Side Effects of New Alzheimer's Drug
- Clinical Diagnostic Test Detects Additional Genetic Variants in Acute Leukemia Patients
- Blood Test Predicts Dementia in Women 25 Years Before Symptoms Begin
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








